Table 3.
Correlation between serum level of lncRNAs HULC, MALAT1, and Linc00152 and clinicopathological characteristics in 129 HCC patients.
| Features | HULC | MALAT1 | Linc00152 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Low (n = 65) | High (n = 64) | P | Low (n = 65) | High (n = 64) | P | Low (n = 65) | High (n = 64) | P | |
| Gender | 0.327 | 0.327 | 0.636 | ||||||
| Male | 54 | 57 | 54 | 57 | 55 | 56 | |||
| Female | 11 | 7 | 11 | 7 | 10 | 8 | |||
| Age | 0.333 | 0.333 | 0.801 | ||||||
| ≤55 | 24 | 29 | 24 | 29 | 26 | 27 | |||
| >55 | 41 | 35 | 41 | 35 | 39 | 37 | |||
| HBsAg | 0.270 | 0.314 | 0.796 | ||||||
| Positive | 53 | 47 | 48 | 52 | 51 | 49 | |||
| Negative | 12 | 17 | 17 | 12 | 14 | 15 | |||
| AFP level | 0.781 | 0.323 | 0.127 | ||||||
| ≤20 ng/mL | 29 | 27 | 31 | 25 | 33 | 41 | |||
| >20 ng/mL | 36 | 37 | 34 | 39 | 32 | 23 | |||
| Tumor size | 0.897 | 0.530 | 0.315 | ||||||
| ≤3 cm | 21 | 20 | 19 | 22 | 18 | 23 | |||
| >3 cm | 44 | 44 | 46 | 42 | 47 | 41 | |||
| Tumor number | 0.611 | 0.668 | 0.611 | ||||||
| Single | 55 | 52 | 53 | 54 | 55 | 52 | |||
| Multiple | 10 | 12 | 12 | 10 | 10 | 12 | |||
| GGT (U/L) | 80 (14-2000) | 77 (13-1034) | 0.944 | 80 (13-2000) | 84 (14-1034) | 0.265 | 61 (13-697) | 98 (15-2000) | 0.012∗ |
| ALT (U/L) | 40 (7-451) | 37 (12-1198) | 0.944 | 37 (7-621) | 37.5 (12-1198) | 0.929 | 34 (7-668) | 40 (12-1198) | 0.378 |
| AST (U/L) | 47 (17-577) | 41 (17-1474) | 0.901 | 38 (18-577) | 51 (17-1474) | 0.142 | 36 (17-577) | 48 (17-1474) | 0.077 |
| TP (g/L) | 69.5 (56.0-80.6) | 68.3 (43.4-84.8) | 0.376 | 68.8 (55.3-84.8) | 68.3 (43.4-84.2) | 0.232 | 68.4 (46.8-79) | 68.7 (43.4-84.8) | 0.644 |
| ALB (g/L) | 40.3 (23.9-48.9) | 39.3 (21.4-48.6) | 0.564 | 40.3 (23.8-48.9) | 39.2 (21.4-47.7) | 0.170 | 40.0 (23.9-47.2) | 40.2 (21.4-48.9) | 0.888 |
∗ P < 0.05. AFP: alpha fetoprotein; GGT: gamma-glutamyl transpeptidase; ALT: alanine aminotransferase; AST: aspartic transaminase; TP: total protein; ALB: albumin.